Katherine Lu is a Director covering the China healthcare sector at Oppenheimer & Co. Inc. She has been following the sector since 2007 and is one of the most experienced China healthcare analysts on the Street. Her research focuses on identifying industry trends and providing proprietary data points, leveraging her broad healthcare industry experience. Katherine joined the firm in the Specialty Pharmaceuticals equity research group in 2006. Prior to that, she was an associate analyst in the Medical Devices and Technology equity research team at Cowen, following large-cap cardiovascular, orthopedics and hospital supplier companies. Prior to Wall Street, Katherine gained six years pharmaceutical industry experience at Roche and Johnson & Johnson and was a healthcare management consultant at Bogart Delafield Ferrier. Ms. Lu graduated sum cum laude from Nanjing University with a B.S. in Chemistry. She earned her M.S. from Iowa State University and her M.B.A. in finance and accounting, with Beta Gamma Sigma Honor, from the Stern School of Business at New York University.